Clinical Trial Update: A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp [Phase 3]

View source ↗

Summary

Phase 3 trial by LEO Pharma comparing Ingenol Disoxate Gel to vehicle in actinic keratosis on the face, chest, or scalp, assessing the incidence of squamous cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Squamous Cell Carcinoma

Drugs mentioned

• Ingenol Disoxate Gel (ingenol disoxate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis, Squamous Cell Carcinoma | Phase 3 | Status: TERMINATED | Results posted: 2019-06-25